Overview
Browse spinoutsLegal name
OXFORD BIOTRANS LIMITED
Region
South East England
Registered address
Unknown
Insolvency history
No
Spinout
Active
LTD
Company profile
Oxford Biotrans Limited
Oxford Biotrans
Oxford Biotrans Limited is a UK company with status active founded in 2013 based in South East England.
CRN
08650667
Founded
2013
Age
12
Corporate ownership
Updated 06 Jun 2026 16:52
4 levels
1 ultimate controller
1
Company
Active
LTD
Oxford Biotrans Limited
CRN 08650667
2
Direct controller
Active
LLP
Touchstone Innovations Businesses LLP
CRN OC333709
3
Intermediate controller
Active
LTD
Ip2Ipo Innovations Limited
CRN 02060639
4
Intermediate controller
Active
LTD
Touchstone Innovations Limited
CRN 05796766
5
Ultimate controller
Active
PLC
Ip Group PLC
CRN 04204490
Company events
Reference milestones and recent Companies House filing stream events.
2 events
20 Aug
2024
Gazette Dissolved Voluntary
GazetteGAZ2(A) | Transaction MzQzMjA0MDYwMmFkaXF6a2N4 | Paper/PDF filed
Published 16 Aug 2024 12:27
14 Aug
2013
Incorporated
InceptionCompany registered at Companies House
Spinout profile
2 entries
Company description
Oxford Biotrans is developing enzyme technology that it claims will be able to transform low-cost raw materials into high-value chemical compounds.
Project impact
The company was founded in September 2013 and is engaged in commercial scale production trials for its first product nootkatone, the high-value grapefruit flavour compound. Initial samples were presented by De Monchy Aromatics, the marketing partner, at industry shows in 2015 and 2016. The Company established its R&D facilities at Milton Park, Didcot, Oxfordshire, employing 15 scientists in process and new product development. The premises was officially opened by Nicola Blackwood, MP, in March 2016. Oxford Biotrans has since developed the process further, achieving commercial scale (cubic metres) reactions in Q4 2016. Full production and commercial launch is planned in Q3 2017, at which point the profits from sales will enable the company to be self-financing. Further VC funding is being considered for expansion of the product portfolio into other sectors. The Company has been featured in, e.g. the Daily Telegraph and the RSC publication Chemistry World.
Oxford Biotrans
2013
Oxford Biotrans
2013
Public funding
3 awards
First funded
2017
Funded years
2017, 2018, 2020
Age at first award
3 years
Projects
2020
Collaborative R&D
Lead participant
Manufacturing a sustainable and cost effective insect repellent
1 Nov 2020 to 31 Mar 2021
Awarded
£98,362
Total cost £98,362
The insect repellent field is dominated by synthetic chemical solutions that have a high environmental impact (such as DEET). Many natural compounds have been shown to be active in this arena, but typically are challenging to produce economically at scale, and/or do not have the same efficacy. One natural compound is nootkatone, the scent and flavour of g...
2018
Feasibility Studies
Lead participant
Continuous production of nootkatone
1 Jun 2018 to 30 Apr 2019
Awarded
£68,805
Total cost £98,294
"The compounds used in the flavour and fragrance (F&F) and agrochemical (such as pesticides) industry today are produced through two main routes. Either through extraction from plant material, much of which is endangered or at very low concentrations, but produces natural compounds, or using synthetic means - multi-step traditional chemistry that typicall...
2017
Feasibility Studies
Lead participant
Innovation in metalloenzyme E.coli fermentation
1 Mar 2017 to 30 Nov 2017
Awarded
£64,365
Total cost £91,950
The compounds used in the flavour and fragrance (F&F) and agrochemical (such as pesticides) industry today are produced through two main routes. Either through extraction from plant material, much of which is endangered or at very low concentrations, but produces natural compounds, or using synthetic means - multi-step traditional chemistry that typically...
Product types
Collaborative R&D
Feasibility Studies